Share on Pinterest Results from a phase 3 clinical trial show promise for a new standard of care for treating people with advanced cervical cancer. AzmanL/Getty Images A phase 3 clinical trial ...

Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in a significant increase in survival rates, a new study shows. The study, ...

In patients with locally advanced cervical cancer receiving chemoradiation, irradiating less than whole uterus led to a low local recurrence rate and less radiation to the bowel but significantly ...

Cervical cancer patients were significantly more likely to be alive and cancer-free after five years when given a short course of chemotherapy prior to chemoradiation. This is the finding of a ...

A 29-year-old Chinese influencer who documented her battle with advanced cervical cancer on social media has died after more ...

Study on the efficacy and toxicity of pamiparib combined with tamoxifen in the treatment of patients with epithelial ovarian cancer with biochemical recurrence during first-line PARPi maintenance ...

The Food and Drug Administration (FDA) has recently approved Keytruda (pembrolizumab) plus chemoradiotherapy for the treatment of patients with stages 3 to 4A cervical cancer. The recent approvalof ...

New results from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study showed that a combination of pembrolizumab and concurrent chemoradiotherapy (CCRT) continues to ...

Induction chemotherapy followed by chemoradiotherapy improves five-year progression-free and overall survival rates in locally advanced cervical cancer patients. The induction chemotherapy regimen led ...

India has launched its first indigenous HPV test, a major milestone in women's healthcare. Designed to make cervical cancer ...

Led by the University of California San Diego, the clinical trial evaluates the safety and efficacy of KRC-01, a radiosensitizer designed to make solid tumors more susceptible to radiation, under a ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. It’s easy to think cervical ...